Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
728 दिनों पहले
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
994 दिनों पहले
Dollar Extends Losses As Markets Cling On To Fed Cut Hopes
The Dollar extended losses during the week ended August 15 amidst strong Fed rate cut expectations, benign consumer price growth, easing geopolitical concerns as well as fading concerns about trade tariff uncertainty.
RTTNews
|
33 मिनटों पहले
U.S. Homebuilder Confidence Edges Slightly Lower In August
The National Association of Home Builders released a report on Monday showing a modest deterioration by U.S. homebuilder confidence in the month of August. The report said the NAHB/Wells Fargo Housing Market Index edged down to 32 in August after inching up to 33 in July. Economists had expected the index to come in unchanged.
RTTNews
|
45 मिनटों पहले
Indian Rupee Rises To 2-week High On GST Reforms Push
The Indian rupee strengthened against the U.S. dollar in the European session on Monday, after Prime Minister Narendra Modi unveiled plans of the biggest tax overhaul since 2017 over the weekend, boosting stocks across sectors like auto, financial, real estate, consumer and cement.
RTTNews
|
2घंटे 31 मिनट पहले
Canadian Market May Open Slightly Weak
Lower Canadian and U.S. futures and weak European markets point to a slightly negative start on Bay Street Monday morning. Firm commodity prices might help limit market's downside.
The focus will be on the meeting between U.S. President Donald Trump and several European leaders, including Ukrainian President Volodymyr Zelenskiy later in the day.
RTTNews
|
3घंटे 6 मिनट पहले
FTSE 100 Slips After Positive Start, Down Marginally
After a modest upmove in early trades, the U.K. market retreated on Monday with investors turning cautious, focusing on the upcoming meeting between U.S. President Donald Trump and several European leaders, after the Trump-Putin summit failed to result in any breakthrough to end the war in Ukraine.
RTTNews
|
3घंटे 46 मिनट पहले
DAX Drifts Lower; Financials Stocks Among Major Losers
After four successive days of gains, the French market is exhibiting weakness on Monday as investors make cautious moves, focusing on the meeting between several European leaders and the U.S. President Donald Trump, after the recent Trump-Putin Summit failed to result in any breakthrough to end the war in Ukraine.
RTTNews
|
4घंटे 11 मिनट पहले
